Skip to main content

Koontz Editorial on Metastatic Prostate Cancer, STAMPEDE

Friday, February 26, 2021

Bridget Koontz, MD, authored More answers and more questions about radiotherapy for metastatic prostate cancer, published in JAMA Oncology on February 18, 2021. 

Dr. Koontz and co-author Thomas Hope, MD, congratulated the STAMPEDE trial group on improving understanding of best treatment options and confirming that focusing more aggressive therapies targeting bulkier sites of disease can improve survival when the systemic burden of disease is low, but noted that more work is yet to be done to understand the role of metastasis-directed therapy and the influence of better imaging on quantifying the burden of disease and predicting benefit of RT for metastatic prostate cancer. 

MedPage Today and Physician's Weekly also covered the JAMA Oncology editorial.